Yüklüyor......
Clinical Outcomes of the HIV Protease Inhibitor Nelfinavir With Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non–Small Cell Lung Cancer: A Phase 1/2 Trial
IMPORTANCE: Local failure after chemoradiotherapy (CT-RT) significantly contributes to mortality in patients with locally advanced non–small cell lung cancer (LA-NSCLC). One approach to improve local control is through targeted radiosensitization of the tumor. OBJECTIVE: To evaluate the dose-limitin...
Kaydedildi:
| Yayımlandı: | JAMA Oncol |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Medical Association
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6707020/ https://ncbi.nlm.nih.gov/pubmed/31436839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2019.2095 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|